课题基金 / 基金详情

Development of therapeutic antibodies targeting carbonic anhydrase IX (CAIX)

Development of therapeutic antibodies targeting carbonic anhydrase IX (CAIX)
开发针对碳酸酐酶 IX (CAIX) 的治疗性抗体
批准号：
291012
负责人：
Dedhar Shoukat R
金额：
$44.44万
依托单位：
B.C. Cancer Research Centre (Vancouver)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-09-01 至 2017-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=291012&lang=en
关键词：
Antibody-Drug Conjugates Cancer Stem Cells Carbonic Anhydrase Ix Circulating Tumor Cells Metastasis Therapeutic Antibodies Tumor Hypoxia Tumor Xenografts

项目摘要

项目成果

Dedhar Shoukat R的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
As tumors grow, areas within the tumor are subjected to low oxygen tension, called hypoxia, due to poorly developed blood vessels. Tumor cells within these "hypoxic" regions adapt to the low oxygen tension by expressing proteins that allow the cells to su
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of Neutrophil Extracellular Trap DNA ( NET-DNA) induced signaling in the progression of Pancreatic Ductal Adenocarcinoma
The Role of Microbiota and Immune Microenvironment in Breast Cancer Metastasis
  • 批准号：
    453393
  • 项目类别：
    Operating Grants
  • 资助金额：
    $4.37万
  • 财政年份：
    2021
  • 负责人：
    Dedhar Shoukat R
  • 依托单位：
    BC Cancer, part of PHSA (Vancouver)
The Role of Tumor Microenvironment in Cancer Progression: Identification and Therapeutic Intervention of Novel Targets
Role of ILK/Rictor complex in the TGF-b and Hippo signaling pathway mediated EMT, cancer stem cell function and tumor progression
海外基金